Key takeaways from the historic approval of a CRISPR-based medicine

We answer questions like, "What is CRISPR?" "How does Casgevy work?" and everything else you're too embarrassed to ask about.

November 16, 2023 Check out STAT+

Sponsored By

Adobe Key questions (and answers) about the historic approval of a CRISPR-based medicine Here are some key questions (and answers) about the approval of Casgevy, a treatment for sickle cell disease and beta thalassemia. By Matthew Herper and Adam Feuerstein and Brittany Trang and Eric Boodman Progress in childhood cancer has stalled for Blacks and Hispanics, report says Advances in childhood cancer have stalled for Black and Hispanic youth over the past two decades, opening a gap in U.S. death rates. By Associated Press STAT+ | FDA cites Dr. Reddy's for quality control problems at a biologics plant This is the latest in a growing list of quality-control issues the FDA found at various Dr. Reddy's plants in India over the last six years. By Ed Silverman Jaida Grey Eagle for STAT How the Bad River Tribe flipped the script on the Native American opioid crisis As the opioid epidemic ravaged the Bad River Reservation, tribal leaders turned to a harm reduction strategy. Their new addiction approach saved lives. By Lev Facher Report: Measles cases and deaths increase worldwide, as childhood vaccinations rates decline Measles vaccination rates have declined in upper-income countries due to hesitancy. In lower-income countries, there are other challenges. By Helen Branswell STAT+ | Bristol wins U.S. approval for lung cancer drug targeting rare genetic mutation The drug was developed by a small biotech company, Turning Point Therapeutics, that was acquired by Bristol in June 2022. By Adam Feuerstein Adobe Colon cancer screening kits have a high rate of untestable samples More than 10% of the tests used for routine colorectal cancer screening contained samples that could not be processed by labs. By Deborah Balthazar

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser